
NYSE:SNN
This summary was created by AI, based on 3 opinions in the last 12 months.
Smith & Nephew PLC (SNN-N) has been positively reviewed by experts due to its recent turnaround and improved financial metrics under new management. The company offers a range of orthopedic services, including joint repairs and dressings, and has gained significant brand recognition in the market. Analysts note that SNN-N is trading at only half the valuation of its larger competitor, Stryker, while exhibiting similar profitability margins. This gap suggests a substantial potential for price appreciation as the company continues to show operational improvements and benefits from industry growth. With a favorable aggregate rating from analysts, there seems to be a strong bullish sentiment surrounding SNN-N's future performance.